Levetiracetam Cristers

Levetiracetam, the active ingredient in Levetiracetam Cristers, is an anticonvulsant presented as an oral tablet for oral use. It treats partial, generalized tonic‑clonic and myoclonic seizures in patients with epilepsy, helping to control seizure activity and improve quality of life.

GNH USA supplies Levetiracetam Cristers as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is used to manage seizure disorders within the epilepsy therapeutic pathway.

Partial seizures: reduces seizure frequency in patients with focal epilepsy. Generalized tonic‑clonic seizures: helps prevent convulsive episodes in generalized epilepsy. Myoclonic seizures: decreases myoclonic jerks in patients with juvenile myoclonic epilepsy.

Levetiracetam may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Fatigue - Somnolence - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior - Blood dyscrasias (e.g., neutropenia, thrombocytopenia) - Severe skin rash or hypersensitivity reactions - Multi‑organ involvement such as hepatitis

When prescribing Levetiracetam, clinicians should consider several precautionary measures to ensure safe use.

Renal impairment: adjust dose based on creatinine clearance. Pregnancy: category B, use only if benefit outweighs risk. Mood changes: monitor for irritability, depression, or suicidal ideation. Abrupt discontinuation: taper gradually to avoid seizure worsening. Hepatic disease: use with caution, although no dose adjustment is typically required. Store at below 25°C: keep in the original packaging, protect from moisture and light.

Levetiracetam can interact with other medicines, affecting its plasma levels or therapeutic effect.

Major Interactions (Avoid): - Carbamazepine: enzyme induction reduces levetiracetam concentrations. - Phenytoin: increases metabolism, lowering efficacy. - Phenobarbital: decreases levetiracetam levels. - Rifampin: strong inducer leading to reduced exposure. - Oral contraceptives: may become less effective due to lowered levetiracetam levels.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam concentrations. - Topiramate: additive CNS depression possible. - Zonisamide: may enhance side‑effect profile.